Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan
· Delayed Price · Currency is TWD 27.85
+0.35 (1.27%)
Mar 10, 2026, 9:00 AM CST
Prince Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Market Capitalization | 1,007 | 802 | 1,267 | - | - | - | Upgrade
|
| Market Cap Growth | 20.09% | -36.72% | - | - | - | - | Upgrade
|
| Enterprise Value | 1,370 | 1,180 | 1,670 | - | - | - | Upgrade
|
| Last Close Price | 27.50 | 21.90 | 34.68 | - | - | - | Upgrade
|
| PE Ratio | - | - | 82.75 | - | - | - | Upgrade
|
| PS Ratio | 1.26 | 1.16 | 1.68 | - | - | - | Upgrade
|
| PB Ratio | 1.36 | 1.11 | 1.64 | - | - | - | Upgrade
|
| P/TBV Ratio | 1.36 | 1.11 | 1.64 | - | - | - | Upgrade
|
| P/FCF Ratio | 33.06 | 28.42 | 2827.58 | - | - | - | Upgrade
|
| P/OCF Ratio | 24.88 | 17.35 | 20.27 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.72 | 1.71 | 2.22 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 21.06 | 259.75 | 21.99 | - | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | 64.79 | - | - | - | Upgrade
|
| EV/FCF Ratio | 45.01 | 41.83 | 3728.36 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.64 | 0.63 | 0.80 | 0.94 | 0.86 | Upgrade
|
| Debt / EBITDA Ratio | 6.77 | 35.06 | 5.81 | 4.35 | 12.80 | - | Upgrade
|
| Debt / FCF Ratio | 14.47 | 16.33 | 1094.55 | 7.25 | 409.55 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.49 | 0.50 | 0.48 | 0.69 | 0.82 | 0.77 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.46 | 78.80 | 4.84 | 3.97 | 12.32 | -17.65 | Upgrade
|
| Net Debt / FCF Ratio | 11.95 | 12.69 | 820.97 | 6.26 | 357.09 | -2.51 | Upgrade
|
| Asset Turnover | 0.59 | 0.50 | 0.56 | 0.55 | 0.35 | 0.25 | Upgrade
|
| Inventory Turnover | 4.38 | 4.33 | 4.11 | 3.68 | 2.79 | 2.29 | Upgrade
|
| Quick Ratio | 0.92 | 0.94 | 1.09 | 0.76 | 0.67 | 0.61 | Upgrade
|
| Current Ratio | 1.63 | 1.56 | 1.85 | 1.59 | 1.37 | 1.14 | Upgrade
|
| Return on Equity (ROE) | -1.47% | -7.16% | 2.14% | 8.18% | -1.37% | -5.49% | Upgrade
|
| Return on Assets (ROA) | 0.11% | -2.24% | 1.19% | 3.26% | -0.06% | -2.65% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.21% | -4.44% | 1.83% | 4.93% | -0.10% | -5.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.20% | -4.40% | 2.20% | 6.10% | -0.10% | -4.90% | Upgrade
|
| Earnings Yield | -1.09% | -6.68% | 1.21% | - | - | - | Upgrade
|
| FCF Yield | 3.03% | 3.52% | 0.03% | - | - | - | Upgrade
|
| Dividend Yield | - | - | 0.72% | - | - | - | Upgrade
|
| Payout Ratio | - | - | 35.46% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.34% | -0.09% | -9.66% | -0.41% | -1.45% | -2.07% | Upgrade
|
| Total Shareholder Return | -0.34% | -0.09% | -8.94% | -0.41% | -1.45% | -2.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.